These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16029324)

  • 1. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes.
    Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H
    Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase.
    Kwon YT; Gupta A; Zhou Y; Nikolic M; Tsai LH
    Curr Biol; 2000 Apr; 10(7):363-72. PubMed ID: 10753743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
    Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK5 regulates cell adhesion and migration in corneal epithelial cells.
    Gao C; Negash S; Guo HT; Ledee D; Wang HS; Zelenka P
    Mol Cancer Res; 2002 Nov; 1(1):12-24. PubMed ID: 12496365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal keratinocytes from uninvolved psoriatic skin exhibit accelerated spreading and focal adhesion kinase responsiveness to fibronectin.
    Chen G; McCormick TS; Hammerberg C; Ryder-Diggs S; Stevens SR; Cooper KD
    J Invest Dermatol; 2001 Dec; 117(6):1538-45. PubMed ID: 11886520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.
    Sadowski T; Dietrich S; Koschinsky F; Sedlacek R
    Mol Biol Cell; 2003 Nov; 14(11):4569-80. PubMed ID: 12937269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death.
    Ahuja HS; Zhu Y; Zakeri Z
    Dev Genet; 1997; 21(4):258-67. PubMed ID: 9438340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells.
    Park SJ; Yang SW; Kim BC
    Biochem Biophys Res Commun; 2016 Apr; 472(3):502-7. PubMed ID: 26966064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions in Cdk5 regulation and function.
    Lim AC; Qu D; Qi RZ
    Neurosignals; 2003; 12(4-5):230-8. PubMed ID: 14673210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
    Schmid G; Strosznajder JB; Wesierska-Gadek J
    Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.
    Li BS; Zhang L; Takahashi S; Ma W; Jaffe H; Kulkarni AB; Pant HC
    EMBO J; 2002 Feb; 21(3):324-33. PubMed ID: 11823425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherins and synaptic plasticity: activity-dependent cyclin-dependent kinase 5 regulation of synaptic beta-catenin-cadherin interactions.
    Schuman EM; Murase S
    Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):749-56. PubMed ID: 12740122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
    Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) on the physiology of cultured human keratinocytes.
    Atanasova G; Jans R; Zhelev N; Mitev V; Poumay Y
    Biochem Pharmacol; 2005 Sep; 70(6):824-36. PubMed ID: 16011834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
    Kesavapany S; Lau KF; McLoughlin DM; Brownlees J; Ackerley S; Leigh PN; Shaw CE; Miller CC
    Eur J Neurosci; 2001 Jan; 13(2):241-7. PubMed ID: 11168528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.